UB Paderborn / Katalog / Suche / in CDI

Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

Clinical infectious diseases, 2021-05, Vol.72 (9), p.e206-e214

2021

Link zum Volltext

Verfügbarkeit prüfen

Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults

Clinical infectious diseases, 2020-04, Vol.70 (8), p.1550-1559

2020

Link zum Volltext

Verfügbarkeit prüfen

Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020

MMWR. Morbidity and mortality weekly report, 2020-09, Vol.69 (37), p.1305-1309

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies

The Journal of infectious diseases, 2019-09, Vol.220 (8), p.1237-1239

2019

Link zum Volltext

Verfügbarkeit prüfen

Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps

The Journal of infectious diseases, 2020-01, Vol.221 (3), p.337-339

2020

Link zum Volltext

Verfügbarkeit prüfen

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease

PloS one, 2010-03, Vol.5 (3), p.e9694-e9694

2010

Link zum Volltext

Verfügbarkeit prüfen

Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research

Vaccine, 2021-06, Vol.39 (28), p.3678-3695

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

Vaccine, 2016-02, Vol.34 (7), p.981-988

2016

Link zum Volltext

Verfügbarkeit prüfen

Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander

PloS one, 2011-03, Vol.6 (3), p.e17780-e17780

2011

Link zum Volltext

Verfügbarkeit prüfen

Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015

Clinical infectious diseases, 2017-03, Vol.64 (5), p.544-550

2017

Link zum Volltext

Verfügbarkeit prüfen

Influenza-associated pediatric deaths in the United States, 2004-2012

Pediatrics (Evanston), 2013-11, Vol.132 (5), p.796

2013

Link zum Volltext

Verfügbarkeit prüfen

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

JAMA internal medicine, 2021-04, Vol.181 (4), p.450

2021

Link zum Volltext

Verfügbarkeit prüfen

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season

The Journal of infectious diseases, 2020-01, Vol.221 (1), p.8-15

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa

PloS one, 2012-01, Vol.7 (1), p.e27793-e27793

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

The Lancet infectious diseases, 2012-03, Vol.12 (3), p.240-248

2012

Link zum Volltext

Verfügbarkeit prüfen

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

Clinical infectious diseases, 2016-12, Vol.63 (12), p.1564-1573

2016

Link zum Volltext

Verfügbarkeit prüfen

The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand

PloS one, 2010-11, Vol.5 (11), p.e15098-e15098

2010

Link zum Volltext

Verfügbarkeit prüfen

Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season

The New England journal of medicine, 2017-08, Vol.377 (6), p.534-543

2017

Link zum Volltext

Verfügbarkeit prüfen

Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

Clinical infectious diseases, 2017-10, Vol.65 (8), p.1289-1297

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic

PloS one, 2012-10, Vol.7 (10), p.e48187-e48187

2012

Link zum Volltext

Verfügbarkeit prüfen

Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale

PloS one, 2021-10, Vol.16 (10), p.e0258482-e0258482

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

The Lancet infectious diseases, 2014-02, Vol.14 (2), p.109-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021

MMWR. Morbidity and mortality weekly report, 2021-07, Vol.70 (29), p.1013-1019

2021

Link zum Volltext

Verfügbarkeit prüfen

Influenza-like Illness, the Time to Seek Healthcare, and Influenza Antiviral Receipt During the 2010-2011 Influenza Season-United States

The Journal of infectious diseases, 2014-08, Vol.210 (4), p.535-544

2014

Link zum Volltext

Verfügbarkeit prüfen

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses

Antiviral research, 2016-05, Vol.129, p.21-38

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults

Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020

Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies

Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease

Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander

Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015

Influenza-associated pediatric deaths in the United States, 2004-2012

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season

Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand

Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season

Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic

Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021

Influenza-like Illness, the Time to Seek Healthcare, and Influenza Antiviral Receipt During the 2010-2011 Influenza Season-United States

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses

Aktive Filter

Suchergebnisse filtern